ChineseChina UKUK DeutschlandDeutschland FranceFrance РоссияРоссия 한국한국 ไทยไทย Việt NamViệt Nam العربيةالعربية ҚазақстанҚазақстан EspañaEspaña MyanmarMyanmar DaiDai

Linking China’s Premium Healthcare · Serving Global Health Needs

Breaking down language, channel and process barriers in cross-border care — making the best doctors your personal doctors.
300 Grade-A partner hospitals · 3,000+ leading experts · one-stop service across all specialties

One-Stop Medical Care in China

  • International flights · Airport pickup · Nearby hotels
  • Multilingual interpreters · Full medical escort
  • Expert matching · Hospital fast-track
  • Full-cycle treatment · Post-op follow-up
Sign in

Miss Nadia · 0 0 0

Patient basic information Patient: Ms Nadia (Nadia Williams) Country: Sierra Leone Disease Diagnosis: Breast Cancer Diagnostic Hospital: H0ZO Treatment Scheme: Intracellular Treatment + Medicines Holidays: 68 days Treatment cost: about 278,231 yuan Treatment effect: Complete relief Description: Ms Nadia is from Sierra Leone and was diagnosed with breast cancer locally. Upon arrival, the International Medical Services Team arranged for the first time multidisciplinary MDT clinics for patients, developed individualized clinical pathways based on patient inspection reports and physical conditions, and provided translation, escort and on-site services throughout the treatment process. After 68 days of systemic treatment and rehabilitation management, the patient's condition gradually improved, and the test indicators returned to normal areas, successfully reaching the standard of hospitalization.

The patient's treatment resulted in complete relief. At the time of his discharge, the medical team developed a detailed return follow-up and rehabilitation plan for him and continued to monitor the recovery through a remote follow-up system. 'Ladies Nadia, experts have criticized this case as a typical case of cross-border suspected seriousness clinical cases.

The multi-disciplinary collaboration mechanism for developing an intracellular treatment+ drug program for breast cancer demonstrates the comprehensive strength of Chinese hospitals in the field of suspected disease clinics and a summary of how international medical services are regulated.

塞拉利昂,乳腺癌,南方医科大学南方医院,国际医疗,来华就医,中国医疗